tiprankstipranks
Trending News
More News >

Structure Therapeutics Holds 2025 Annual Shareholders Meeting

Story Highlights
Structure Therapeutics Holds 2025 Annual Shareholders Meeting

Don’t Miss TipRanks’ Half-Year Sale

Structure Therapeutics, Inc. Sponsored ADR ( (GPCR) ) has shared an update.

On June 23, 2025, Structure Therapeutics Inc. held its 2025 Annual General Meeting of Shareholders. During the meeting, shareholders elected Eric Dobmeier and Joanne Waldstreicher, M.D. as Class II directors to serve until the 2028 Annual General Meeting. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Furthermore, the compensation of the company’s named executive officers was approved, and it was decided that future advisory votes on executive compensation will be held annually.

The most recent analyst rating on (GPCR) stock is a Buy with a $91.00 price target. To see the full list of analyst forecasts on Structure Therapeutics, Inc. Sponsored ADR stock, see the GPCR Stock Forecast page.

Spark’s Take on GPCR Stock

According to Spark, TipRanks’ AI Analyst, GPCR is a Underperform.

Structure Therapeutics, Inc.’s overall score is largely impacted by its financial performance, reflecting significant financial sustainability risks due to zero revenues and increasing losses, despite strong cash positions. The technical analysis provides a mixed view with some short-term momentum but longer-term concerns. The valuation remains challenging with a negative P/E ratio, indicating a speculative investment reliant on future success in R&D and commercialization.

To see Spark’s full report on GPCR stock, click here.

More about Structure Therapeutics, Inc. Sponsored ADR

Average Trading Volume: 989,849

Technical Sentiment Signal: Sell

Current Market Cap: $1.29B

See more insights into GPCR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1